Stoke Therapeutics, Inc. (STOK) Profit Margin
Stoke Therapeutics, Inc. (STOK) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2019-12-31 | N/A |
| 2020-12-31 | N/A |
| 2021-12-31 | N/A |
| 2022-12-31 | -814.73% |
| 2023-12-31 | -1192.47% |
| 2024-12-31 | -243.42% |
| 2025-12-31 | -3.73% |
How STOK compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| ARWR | Arrowhead Pharmaceuticals Inc. | -0.20% |
| ACHV | Achieve Life Sciences Inc. | -24.38% |
| VRCA | Verrica Pharmaceuticals Inc. | -50.27% |
| QTRX | Quanterix Corporation | -77.14% |
| MRNA | Moderna Inc. | -145.16% |
These are five companies in the same sector as STOK with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Stoke Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("STOK", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | STOK | $29.81 | -0.60% | 0.71M |
| 3 | ||||
| 4 | ||||
| 5 |